Matches in Wikidata for { <http://www.wikidata.org/entity/Q59649861> ?p ?o ?g. }
Showing items 1 to 46 of
46
with 100 items per page.
- Q59649861 description "article scientifique publié en 2018" @default.
- Q59649861 description "artículu científicu espublizáu n'agostu de 2018" @default.
- Q59649861 description "scientific article published on 23 August 2018" @default.
- Q59649861 description "wetenschappelijk artikel" @default.
- Q59649861 description "наукова стаття, опублікована в жовтні 2018" @default.
- Q59649861 name "Immunomodulatory effects of BRAF and MEK inhibitors: Implications for Melanoma therapy" @default.
- Q59649861 name "Immunomodulatory effects of BRAF and MEK inhibitors: Implications for Melanoma therapy" @default.
- Q59649861 type Item @default.
- Q59649861 label "Immunomodulatory effects of BRAF and MEK inhibitors: Implications for Melanoma therapy" @default.
- Q59649861 label "Immunomodulatory effects of BRAF and MEK inhibitors: Implications for Melanoma therapy" @default.
- Q59649861 prefLabel "Immunomodulatory effects of BRAF and MEK inhibitors: Implications for Melanoma therapy" @default.
- Q59649861 prefLabel "Immunomodulatory effects of BRAF and MEK inhibitors: Implications for Melanoma therapy" @default.
- Q59649861 P1433 Q59649861-BC91371F-017D-435B-83B4-7CAB9BD94D51 @default.
- Q59649861 P1476 Q59649861-C2163092-7683-4EC0-9D18-B4595DE38BDC @default.
- Q59649861 P2093 Q59649861-0A2F9FF2-1262-4B2C-8695-141BA085EA6E @default.
- Q59649861 P2093 Q59649861-21C3CFD9-8C22-49FE-B113-A4715982730D @default.
- Q59649861 P2093 Q59649861-423FAE73-AD47-4C70-9A7E-17881CC04FF3 @default.
- Q59649861 P2093 Q59649861-81CC9D2E-5D9B-4735-B9C4-DC77CB7A6A72 @default.
- Q59649861 P2093 Q59649861-BB3076CB-CAE3-4307-8EB6-86EAF326F3A4 @default.
- Q59649861 P2093 Q59649861-EC04C356-7462-4AA1-9EC0-DB9449683F78 @default.
- Q59649861 P2860 Q59649861-DEA69EC8-D4B8-4BD1-9406-A98FC1F76B66 @default.
- Q59649861 P304 Q59649861-89748C16-61CA-4899-9976-7AF5C19F0E8C @default.
- Q59649861 P31 Q59649861-1463A1AC-7A91-4CBC-811B-0F2914401B93 @default.
- Q59649861 P356 Q59649861-606B537B-271F-4114-AAC7-D83440E4533E @default.
- Q59649861 P478 Q59649861-B4F104F2-5A04-4DF5-AD3E-355F8FE0120A @default.
- Q59649861 P50 Q59649861-BA7BAFB8-6514-4FC5-A985-B3DDD1D7C524 @default.
- Q59649861 P577 Q59649861-9AAA1A18-4E07-4C7B-8E33-9FAC5F5088E2 @default.
- Q59649861 P698 Q59649861-6D48EC70-B373-4A11-8936-9796089FA7F5 @default.
- Q59649861 P356 J.PHRS.2018.08.019 @default.
- Q59649861 P698 30145328 @default.
- Q59649861 P1433 Q15724622 @default.
- Q59649861 P1476 "Immunomodulatory effects of BRAF and MEK inhibitors: Implications for Melanoma therapy" @default.
- Q59649861 P2093 "Dana Westphal" @default.
- Q59649861 P2093 "Friedegund Meier" @default.
- Q59649861 P2093 "Marc Schmitz" @default.
- Q59649861 P2093 "Marvin Kuske" @default.
- Q59649861 P2093 "Rebekka Wehner" @default.
- Q59649861 P2093 "Stefan Beissert" @default.
- Q59649861 P2860 Q36638192 @default.
- Q59649861 P304 "151-159" @default.
- Q59649861 P31 Q13442814 @default.
- Q59649861 P356 "10.1016/J.PHRS.2018.08.019" @default.
- Q59649861 P478 "136" @default.
- Q59649861 P50 Q37374990 @default.
- Q59649861 P577 "2018-08-23T00:00:00Z" @default.
- Q59649861 P698 "30145328" @default.